cropped-Tim-Lau1.jpg
Vancouver General Hospital
Pharmaceutical Sciences
855 West 12th Avenue
Vancouver, British Columbia V5Z 1M9
Canada
Contact Info
phone: 6048754111 ext:63361
tim.lau@vch.ca
Position(s)
Pharmacotherapeutic Specialist, Infectious Diseases, Pharmaceutical Sciences, Vancouver General Hospital
Clinical Associate Professor, Faculty of Pharmaceutical Sciences, UBC
Research interests

Antimicrobial stewardship
Antimicrobial and vaccine utilization
Multi-disciplinary initiatives

Publications

Thalakada R, Legal M, Lau TTY, Luey T, Batterink J, Ensom MHH. Development and Validation of a Novel Vancomycin Dosing Nomogram for Achieving High-Target Trough Levels at Two Major Canadian Teaching Hospitals. Canadian Journal of Hospital Pharmacy 2012;65(3):180–187.

Samilski JAE, Lau TTY, Elbe DHT, Aulakh AK, Lun EMC. Drug Use Evaluation of Moxifloxacin Using a Handheld Electronic Device at a Canadian Teaching Hospital. Pharmacy and Therapeutics Journal 2012;37(5):291-99.

Wilby KJ, Lau TTY, Gilchrist SE, Ensom MHH. Mosquirix® (RTS,S): a novel vaccine for the prevention of Plasmodium falciparum malaria. The Annals of Pharmacotherapy 2012;46:384-93. DOI: 10.1345/aph.1Q634.

Black E, Lau TTY, Ensom MHH. Vancomycin-induced Neutropenia: Is it Dose- or Duration-related? The Annals of Pharmacotherapy 2011;45(5):629-638. DOI 10.1345/aph.1P583.

Infectious Diseases Working Group, Clinical Care Advisory Group (Bowie W, Skippen P, Marra F, Stiver G, Lau T, Henry B, Chong E). British Columbia’s H1N1 Pandemic Influenza Response Plan (2009): Antibiotics for Secondary Pneumonia in Community and Acute Care Settings. BC Ministry of Health, October 19, 2009.